Literature DB >> 12470148

Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma.

Teresa M Walker1, Paul R Van Ginkel, Ricardo L Gee, Hoda Ahmadi, Lalita Subramanian, Bruce R Ksander, Lorraine F Meisner, Daniel M Albert, Arthur S Polans.   

Abstract

OBJECTIVE: To study the expression of angiogenic factors Cyr61 and tissue factor (TF) in uveal melanoma and its correlation with blood vessel density.
METHODS: Suppression subtractive hybridization was used to identify genes that are differentially expressed between cell lines of uveal melanoma and normal uveal melanocytes. Expression of these genes was subsequently verified in primary uveal melanomas and correlated with the number of blood vessels in archival specimens by immunohistochemical analysis.
RESULTS: Cyr61 and TF are expressed at elevated levels in cell lines of uveal melanoma compared with normal uveal melanocytes. Duplication of a region of chromosome arm 1p, encompassing the genes encoding Cyr61 and TF, was observed in the melanoma cell line used in the initial subtractive hybridization. Both genes are also expressed in primary uveal melanomas, and a correlation was found between expression of TF and the number of blood vessels in archival specimens.
CONCLUSIONS: Cyr61 and TF may contribute to the angiogenic phenotype associated with uveal melanoma. A region of chromosome arm 1p also may contain oncogenes or tumor suppressor genes pertinent to the origins of this type of ocular tumor. CLINICAL RELEVANCE: New immunotherapies have been devised for the treatment of cancer based on the expression of TF. Similar approaches may be effective in treating uveal melanoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470148     DOI: 10.1001/archopht.120.12.1719

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

Review 1.  Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis).

Authors:  Martine J Jager; J Antonio Bermudez Magner; Bruce R Ksander; Sander R Dubovy
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

2.  Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.

Authors:  Andrey S Dobroff; Hua Wang; Vladislava O Melnikova; Gabriel J Villares; Maya Zigler; Li Huang; Menashe Bar-Eli
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

3.  Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma.

Authors:  Lalita Subramanian; John W Crabb; Jos Cox; Isabelle Durussel; Teresa M Walker; Paul R van Ginkel; Saswati Bhattacharya; Julia M Dellaria; Krzysztof Palczewski; Arthur S Polans
Journal:  Biochemistry       Date:  2004-09-07       Impact factor: 3.162

4.  Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation.

Authors:  M T Sandinha; M A Farquharson; F Roberts
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

5.  Identification of differentially expressed genes in uveal melanoma using suppressive subtractive hybridization.

Authors:  Solange Landreville; Caroline B Lupien; Francois Vigneault; Manon Gaudreault; Mélissa Mathieu; Alain P Rousseau; Sylvain L Guérin; Christian Salesse
Journal:  Mol Vis       Date:  2011-05-13       Impact factor: 2.367

6.  Repression of genes involved in melanocyte differentiation in uveal melanoma.

Authors:  Marjorie-Allison Bergeron; Sophie Champagne; Manon Gaudreault; Alexandre Deschambeault; Solange Landreville
Journal:  Mol Vis       Date:  2012-07-04       Impact factor: 2.367

Review 7.  Uveal melanoma: epidemiology, etiology, and treatment of primary disease.

Authors:  Benjamin A Krantz; Nikita Dave; Kimberly M Komatsubara; Brian P Marr; Richard D Carvajal
Journal:  Clin Ophthalmol       Date:  2017-01-31

Review 8.  Treatment of uveal melanoma: where are we now?

Authors:  Jessica Yang; Daniel K Manson; Brian P Marr; Richard D Carvajal
Journal:  Ther Adv Med Oncol       Date:  2018-02-21       Impact factor: 8.168

9.  Cyr61 Promotes Inflammation of a Gouty Arthritis Model in Rats.

Authors:  Mi Zhou; Kan Ze; Liang Hua; Liu Liu; Le Kuai; Ming Zhang; Bin Li; Yifei Wang; Xin Li
Journal:  Mediators Inflamm       Date:  2020-07-24       Impact factor: 4.711

10.  Huzhang Tongfeng Granule Improves Monosodium Urate-Induced Inflammation of Gouty Arthritis Rat Model by Downregulation of Cyr61 and Related Cytokines.

Authors:  Mi Zhou; Kan Ze; Yifei Wang; Xin Li; Liang Hua; Yi Lu; Xi Chen; Xiaojie Ding; Siting Chen; Yi Ru; Ming Zhang; Bin Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.